News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Alex Keown

news@biospace.com

BioSpace News - By Alex Keown
BIO2017: States, Countries Attempt to Woo Companies at BIO 6/23/2017
BIO2017: Companies Use BIO Event to Network and Develop Collaborative Partnerships 6/23/2017
Feds Accuse 'Greedy' Pharmakon Execs of Selling Drugs That Sickened Babies 6/23/2017
bluebird bio (BLUE) Touts Impressive Data From Late-Stage Gene Therapy Study 6/23/2017
FDA Calls Cara Therapeutics (CARA)' Kidney Disease Drug a Breakthrough, Stock Soars 6/23/2017
OvaScience (OVAS) Slashes 50% of Workforce, Replaces CEO 6/22/2017
Employee in Critical Condition After Shooting at San Diego Biotech Phamatech 6/22/2017
Amgen (AMGN) Goes on the Defensive When Critics Call Its Pipeline a Dud 6/22/2017
Seattle Genetics (SGEN) Takes Another Hit as the FDA Slaps Hold on IND for Vadastuximab Talirine 6/22/2017
Cambridge Biotech Startup Rubius Banks $120 Million, Hopes to Hire 60 New Staffers 6/22/2017
BIO2017: Biotech Dealmaking Will Be Robust in 2017, But Remain Below 2015 Highs 6/22/2017
BIO2017: BIO Urges Biotech Leaders to Get Active on Legislation 6/22/2017
BIO2017: Eli Lilly (LLY) Clinical Development Head Looks to Innovate, Continue Alzheimer’s Research 6/21/2017
BIO2017: Former UK Prime Minister Cameron Calls for More Alzheimer’s Research 6/21/2017
BIO2017: BIO Leaders Honor Memory of Genzyme’s Henri Termeer 6/21/2017
BIO2017: Ann Romney Shares Journey Through MS Treatments, Founding of Neurological Research Center 6/21/2017
Biogen (BIIB) Brings Ex-Shire (SHPG) Exec Into C-Suite 6/21/2017
Governor Launches $500 Million Initiative to Keep Massachusetts' Biotech World Booming 6/20/2017
Bay Area Tech Titan Sean Parker Reaches Out to Unheard-Of Biotech to Confront Immunotherapy 6/20/2017
Inovio Pharma (INO) CEO Forging Multiple Deals, Expanding Pipeline and Adding 100 New Jobs 6/20/2017
Why This Tiny Massachusetts Biotech Could be a New M&A Target for Drug Giants Like Gilead (GILD) and Celgene (CELG) 6/20/2017
Bayer (BAY) Puts Down More Roots in Massachusetts With New Life Science Center 6/20/2017
New Data Reveals This New York Biotech's Pipeline Could be a Game Changer 6/19/2017
Checkmate Notches $27 Million and Taps Ex-FORUM Pharma Exec as COO 6/19/2017
Roche (RHHBY)'s Former New Jersey Site to Become a Life Sciences Campus 6/19/2017
Sonar Products, Stratus Pharma Ordered to Cease Operations 6/16/2017
Why Drug Giants Like Merck & Co. (MRK) and AstraZeneca PLC (AZN) Scientists are Looking in the Toilet for New Cancer Treatments 6/16/2017
Why This Overlooked New Jersey Biotech Could be an Orphan Underdog 6/16/2017
Epizyme (EPZM) Falls as Investors Take in Disappointing Phase II Data 6/16/2017
New Biotech Incubator Just Opened Up in the Big Apple—With Room for 25 Startups 6/16/2017
AstraZeneca PLC (AZN) CEO Warns of More Setbacks, Admits Company is Still Vulnerable to a Takeover 6/15/2017
Meet the Scientist Finding Success at Other Biotechs Working on Old Pfizer (PFE) Compounds 6/14/2017
Hiring Underway at PsiOxus' New Facility in Philadelphia 6/14/2017
Alexion (ALXN) Poaches Biogen (BIIB)'s Longtime CFO 6/14/2017
Deaths Force Merck & Co. (MRK) to Halt Enrollment for Blood Cancer Studies 6/14/2017
Landmark Ruling: Amgen (AMGN) Loses Bid to Delay Biosimilars 6/13/2017
Bay Area's Coherus Craters After the FDA Spurns Its Biosimilar for Amgen (AMGN)'s Neulasta 6/13/2017
Meet 7 Bay Area Scientists Changing the Face of Biotech 6/13/2017
Meet GammaDelta Therapeutics's CEO—The Scientist Who Helped GlaxoSmithKline (GSK) Launch 7 Cancer Drugs 6/13/2017
SoCal's Regulus (RGLS) Sinks After AstraZeneca PLC (AZN) Bails on Lead NASH Drug 6/13/2017
Hundreds of Patient Deaths Linked to Roche (RHHBY)'s RA Drug Actemra 6/12/2017
The Single Best Hep C Drug Stock to Buy in 2017—Hint, It's Not Gilead (GILD) 6/12/2017
Johnson & Johnson (JNJ) Poaches Merck & Co. (MRK) Exec to Run Pharma R&D 6/12/2017
2 Biotechs Insiders Just Bought $70 Million Worth of Stock In 6/12/2017
First Time Ever: FDA Asks Endo Pharma (ENDP) to Stop Selling Opana ER Amid Opioid Crisis 6/9/2017
Booming Glenmark Pharma Could File One NDA Each Year For 10 Years 6/9/2017
Tiny Bay Area Biotech Wants to Rattle the Billion-Dollar Injectable Drug Markets With a Single Pill 6/8/2017
Loxo Oncology (LOXO) Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It 6/8/2017
Debt-Ridden Valeant (VRX) Nears Sale of Its $2 Billion Eye Care Biz Bausch & Lomb 6/7/2017
AstraZeneca PLC (AZN) Eases Its Migraine With $302 Million Sale 6/7/2017
Ramaswamy Launches Another New Biotech to Work on Phase III-Ready Drug From Merck & Co. (MRK) 6/7/2017
Novan Lays Off 20% of Workforce, Switches Up C-Suite 6/6/2017
Acorda (ACOR) Jumps as Parkinson’s Drug Performs Well in Late-Stage Study 6/6/2017
Perrigo (PRGO) CEO to Retire After Only 14 Months on the Job 6/6/2017
Cambridge's 30-Person Cure Forward to Dissolve This Week 6/6/2017
Genentech (RHHBY)’s Perjeta-Based Adjuvant Breast Cancer Care Shows Minor Improvement, Puma Biotech (PBYI) Shares Jump 6/6/2017
New Immuno-Onco Deal With Merck KGaA (MKGAF.PK) Could Make This UK Biotech a $1 Billion Company 6/6/2017
Philadelphia Drugmaker Iroko Pharma Pink Slips Another 122 Employees 6/5/2017
New Alexion (ALXN) CEO Brings Two Former Baxalta (BXLT) Pals and One Pfizer (PFE) Alum Into the C-Suite 6/5/2017
Elated Bristol-Myers Squibb (BMY), Seattle Genetics (SGEN) Rewrite Agreement to Push Promising Drug Combo Into Phase III 6/5/2017
Founding CEO of Editas Medicine (EDIT) Lands New Gig at Top Biotech VC Firm 6/2/2017
Bicycle Therapeutics Snags $52 Million to Take Early Stage Drugs Into Clinic 6/1/2017
Massachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline 6/1/2017
CRISPR (CRSP), Editas Medicine (EDIT) and Intellia Fall as Scientific Paper Warns of Unintended Mutations Linked to Gene-Editing 6/1/2017
Akari CEO Abruptly Steps Down Amid Investigation Into Phase II Trial Data 6/1/2017
Struggling MannKind (MNKD) Replaces CEO 5/31/2017
Why This Tiny SoCal Biopharma Could be a Real Threat to Mylan (MYL) 5/31/2017
Bay Area Biotech Inks IBD Deal Worth $990 Million With Drug Giant Johnson & Johnson (JNJ) 5/31/2017
Cambridge Biotech Enumeral Biomedical (ENUM) Has Cash to Fund Its Operations Only Into Next Month 5/30/2017
Aerie (AERI) Rockets as Eye Drug Wows in Key Phase III Study 5/30/2017
How Much Juno (JUNO) Spent on Its Failed CAR-T Drug 5/30/2017
Roche (RHHBY)'s New MS Drug Linked to Deadly Brain Infection 5/30/2017
Recruiting Veterans for Life Science Jobs is a Focus at BIO 5/30/2017
26 Patients Dead After Replacing Controller for Abbott (ABT)'s HeartMate II Blood Pumps at Home 5/30/2017
Why Puma Biotech (PBYI) Could Get Acquired Between July to September of This Year 5/30/2017
New FDA Head Lifts Hiring Freeze, Takes Aim at the Next Martin Shkreli and Marathon Pharma 5/30/2017
Biocryst (BCRX) Stock Caught Fire After Reporting Positive Phase II HAE Data 5/26/2017
Top 5 Likable CEOs in Biotech and Pharma 5/26/2017
Silicon Valley VCs Quietly Hiring Biotech Experts 5/25/2017
Puma Biotech (PBYI) Defies Odds, Wins FDA Backing for Breast Cancer Drug 5/25/2017
tranSMART Foundation Teams With IBM (IBM) to Bring Translational Medicine Data to Scientists, Merges With I2B2 5/24/2017
Massive FDA and NIH Cuts in Trump's Outlined Budget Plan 5/24/2017
Neurocrine (NBIX) Tanks as Tourette Syndrome Drug Flunks Mid-Stage Study 5/24/2017
These 3 Biotechs Could Lead the Next Biotech Boom 5/24/2017
Market Just Got More Crowded as Regeneron (REGN), Sanofi (SNY)'s New RA Drug Wins FDA Approval 5/24/2017
AstraZeneca PLC (AZN) Offloads Heart Drugs to Recordati in $300 Million Deal to Pump Up R&D 5/23/2017
Nabriva Commences Previously Announced Tender Offer Related To The Proposed Redomicile Of Its Holding Company From Austria To Ireland 5/23/2017
Puma Biotech (PBYI) Surges on the FDA's Positive Breast Cancer Review 5/23/2017
Amgen (AMGN) Faces Setback as Osteoporosis Drug is Linked to Serious Heart Side Effects 5/23/2017
Amazon (AMZN) Hiring to Break Into the Pharmaceuticals Business 5/23/2017
Novartis AG (NVS) to Shed Another 500 Jobs, Add 350 High-Tech Jobs 5/19/2017
Apple (AAPL) CEO Spotted Wearing a Prototype Glucose-Tracker on the Apple Watch 5/19/2017
Two NIH Sources Reveal President Trump is Considering New Cuts to Biomedical Research 5/19/2017
Genentech (RHHBY) Will Pass Out More Cash to Researchers to Stand Up to Cancer 5/18/2017
Short Seller Who Unraveled Valeant (VRX) Zeroes in On This Massachusetts Biotech 5/18/2017
AstraZeneca PLC (AZN) Sues Former Exec After GlaxoSmithKline (GSK) Poaches Him Away to Run Its Largest Business 5/18/2017
Shire (SHPG)'s $6.5 Billion Dyax (DYAX) Bet Pays Off as Lanadelumab Wows in Phase III Study 5/18/2017
Teva (TEVA) Cuts Another 500 Jobs, May Hire CEO Who Isn’t Israeli 5/18/2017
Spotted in the Bay Area: Former FDA Head in Talks to Join Google (GOOG)'s Verily (GOOGL) 5/18/2017
Cancer Biotech G1 Therapeutics (GTHX) Grabs $105 Million in IPO 5/17/2017
Thermo Fisher Scientific (TMO) Bags Patheon (PTHN) in $7.2 Billion Deal, Pantheon Stock Soars 5/17/2017
How Merck & Co. (MRK) Could Have Lucked Into a $10 Billion Drug 5/17/2017
New Study Finds High Prescription Drug Costs Are Not Driving Up U.S. Healthcare Costs 5/17/2017
Synlogic Takes Chance on Failed Austin Biotech, Finds Spot in the Nasdaq 5/16/2017
Biotech Loses a Legend: Genzyme Founder and Longtime CEO Dies at 71 5/16/2017
Safety Concerns Raised as Ionis Pharma (IONS)'s Inotersen Meets Both Primary Endpoints in Late-Stage Study 5/16/2017
More R&D Fat is Trimmed as Biogen (BIIB) Closes Doors on UK's Convergence Pharma 5/15/2017
Struggling XBiotech (XBIT) Quietly Discloses Exec Resignation 5/15/2017
SoCal's Capricor to Reduce Workforce and Shift Focus After Discouraging Trial Results 5/12/2017
Stock Falls as FDA Slaps Warning on Researcher Studying Ionis Pharma (IONS)'s IONIS-TTRrx 5/12/2017
It's Official: New FDA Head Confirmed 5/11/2017
Pacific Biosciences (PACB) Inks Huge Lease at Revamped Bay Area Site 5/11/2017
Why All Eyes Will be on Alnylam (ALNY) and Any Updates of Its APOLLO Phase III Trial This Friday 5/11/2017
BeyondSpring CEO Makes 3 Big Predictions for Biotech’s Future in 20 Years 5/11/2017
Google (GOOG)'s Verily Scientist Left to Co-Found Stealth Health Startup Named Mindstrong 5/11/2017
Turing Receives $100 Million Offer on Drug That Made Martin Shkreli Famous 5/10/2017
With 80 New Jobs Already, Lupin (LUPN.BO) Aims to Create Even More Opportunities at New Jersey Site 5/10/2017
These 2 Biotechs' Shark Antibodies Have Caught Amgen (AMGN)'s Eye 5/10/2017
SCA Pharma to Open New Facility in Connecticut, 360 Jobs Expected 5/10/2017
Google (GOOG)'s Verily Loses High-Profile Scientist 5/10/2017
Takeda (TKPYY), Abingworth Infuse $100 Million Into a Tiny Biotech, Sealing an Option for M&A 5/10/2017
Catastrophic Year for Bay Area's OncoMed (OMED) Continues as Lead Drug Comes Crashing Down in Phase II Study 5/9/2017
The World's Richest Doctor Loses Top NantHealth (NH) Exec 5/9/2017
Regulus (RGLS) CEO Out, 30% of Workforce Slashed in Restructuring 5/9/2017
Stock Soars as Immunomedics (IMMU) CEO, COO Exit and Seattle Genetics (SGEN) Dumps $2 Billion Deal 5/8/2017
Mitsubishi Tanabe Wins FDA Approval for Radicava, the First New ALS Drug in 22 Years 5/8/2017
5 Biotech CEOs That Made Bank Even as Their Companies Tanked on Wall Street 5/5/2017
Pfizer (PFE) Giving Out Cutting-Edge Cancer Drug for Free While Awaiting NHS Decision 5/5/2017
Genentech (RHHBY) Exec Jumps Ship to Become CMO at Gritstone Oncology 5/5/2017
PE Firm in Talks to Buy VWR (VWR) in Deal Worth $5 Billion 5/4/2017
Cytori (CYTX) Restarting Texas Facility it Inherited From Azaya Therapeutics Buyout Deal 5/4/2017
Feds Appeared at Perrigo (PRGO)'s HQ With Search Warrants Yesterday 5/4/2017
AngioDynamics (ANGO) CEO Highlights First Year and Looks to the Future 5/4/2017
Backed By Two Drug Powerhouses, GenSight Alum Launches New Biotech With $40 Million 5/4/2017
Celgene (CELG) Poaches Top R&D Cancer Exec From Merck & Co. (MRK) 5/3/2017
Allergan (AGN) R&D Chief: Company Forges Ahead With Migraine Treatments 5/3/2017
Congress Ignores Trump: the NIH Will Get $2 Billion Boost Despite Proposed Cuts 5/3/2017
Theranos Quietly Settles Lawsuits With One of Its Biggest Investors 5/3/2017
This Boston Biotech Gets $57.5 Million Upfront, $2.1 Billion Commitment From Drug Giant AstraZeneca PLC (AZN) 5/3/2017
On a Roll: Magenta Therapeutics Nabs Another $50 Million, a Drug From Novartis AG (NVS) and Deal With Be The Match BioTherapies 5/2/2017
Agreement Reached After Novo Nordisk A/S (NVO) is Accused of Disguising Salespeople and Dealing Kickbacks 5/2/2017
Tiny Parion Sciences Seals Dry Eye Drug Deal Worth $535 Million With Biotech Giant Shire (SHPG) 5/2/2017
Gene-Editing Leader Horizon Discovery to Go on Global Hiring Spree 5/2/2017
Why Bristol-Myers Squibb (BMY) Just Became an Even More Attractive Takeover Target 5/2/2017
Biotech Unicorn Moderna's Vaccine Performs Well in First Human Trial 5/1/2017
Biogen (BIIB)'s Ex-CEO George Scangos Left a Very Wealthy Man 4/28/2017
AstraZeneca PLC (AZN) Dumps Two Drugs From Pipeline, Causing an Ex-Partner's Stock to Tank Some More 4/28/2017
Filings Reveal Bristol-Myers Squibb (BMY) Passes on Option to Buy f-Star 4/28/2017
Massachusetts' Avedro Banks $42 Million, Opens New Facility and Will Continue to Expand Its Team 4/27/2017
9 Top Biotechs That Have Stashed Away a $133 Billion M&A Cashpile Overseas 4/27/2017
AstraZeneca PLC (AZN)'s Cambridge Headcount Hits 2,000 as Its New HQ Hit Budget Woes 4/27/2017
AstraZeneca PLC (AZN)'s Lung Cancer Trial Gets Delayed 4/27/2017
Regeneron (REGN)'s Top Execs Get a Huge Pay Cut in 2016 But It's Still More Than Most of Us Have Ever Dreamed of 4/27/2017
Beleaguered Bay Area Pharma OncoMed (OMED) Lays Off Half Its Workforce 4/26/2017
Texas-based ePatientFinder CEO Looks to Revolutionize Clinical Trial Recruitment 4/25/2017
Now Theranos is Accused of Running Fake Tests and Setting Up Secret Company 4/25/2017
Germany's Fresenius Kabi AG Slams Down $4.3 Billion for Akorn (AKN) in U.S. Expansion 4/25/2017
Ophthotech (OPHT) Co-Founder and CEO to Step Down, CFO Named New Leader 4/25/2017
Trump Invites Top Biotech Execs and Researchers for Meeting at the White House Next Month 4/25/2017
Unstoppable Celgene (CELG) to Take Over Amgen (AMGN)'s Former Space in Cambridge 4/24/2017
Turing CEO and Shkreli Associate Exits Top Post, CSO Takes Over 4/24/2017
Novartis AG (NVS) Hires Bank of America (BAC) to Officially Review Alcon (ACL) Options 4/24/2017
Elon Musk Outlines Plans for Bay Area Brain Implants Startup Neuralink 4/24/2017
Up to 4,100 Children Victims of Sanofi (SNY)'s Epilepsy Drug, Says French Regulator 4/21/2017
Editas Medicine (EDIT), Veritas Genetics Co-Founder and Biotech Phenom George Church Makes Time's 100 'Most Influential' List 4/21/2017
Investors Accuse Theranos of Threatening to File for Bankruptcy If They Didn't Give Up Their Right to Sue 4/21/2017
Bay Area's Atara Biotherapeutics (ATRA) Leases Huge Space in SoCal 4/20/2017
Johnson & Johnson (JNJ) Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner 4/20/2017
Tension Rises Between Vertex (VRTX) and Its Religious Investors Over Lobbying Disclosures 4/20/2017
Where Billionaire-Led Intrexon (XON) Could Be in 10 Years 4/20/2017
Juno (JUNO) Taps Ex-Genentech (RHHBY) Scientist to Head Up R&D at New Bay Area Office 4/20/2017
AbbVie (ABBV)'s PARP Inhibitor Fails to Deliver in Two Late-Stage Studies 4/20/2017
Cancer Biotech G1 Therapeutics Files for $115 Million IPO 4/19/2017
Antibiotics Maker Steri-Pharma Wants to Create 72 New Jobs in New York 4/19/2017
This Year’s Superbug Norovirus Sickens Hundreds of Millions, Prompting Urgent Race for Vaccine 4/18/2017
Getting Off Easy? Embattled Theranos Could Have a Lab Again in 2019 4/18/2017
Hanmi Pharma (128940.KS) Charged for Failure to Report Patient Death in Olmutinib Study 4/18/2017
When It Rains, It Pours: Bay Area's OncoMed (OMED) Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study 4/18/2017
Pharma Giant Merck Sharp & Dohme (MRK) Could Bring 600 New Jobs to Austin 4/18/2017
Genentech (RHHBY) Shows Off Late-Stage Hemophilia A Data 4/17/2017
Drug Giant Aspen Pharmacare Plotted to Destroy Cancer Medicine to Jack Up Prices 4/17/2017
Boston's SV Life Sciences Unveils Name Change, Debuts $400M Fund for Biotech 4/14/2017
Abbott (ABT) Seals Alere (ALR) Deal at Lower Price, Ending Legal Battle 4/14/2017
2 Drugmakers Seek to Block Arkansas from Using Their Drugs to Execute 7 Men 4/14/2017
Nexvet Stock Skyrockets on $85 Million Takeover Offer from Zoetis (ZTS) 4/14/2017
Biotech Startup Vyriad Graduates from Mayo Clinic Incubator to Larger Space 4/13/2017
Wait For It! Trump Tapped Congressman to Become the Next 'Drug Czar' 4/13/2017
It's Not Over Yet: Martin Shkreli Stays Mum on Plans for New Biotech Software Company 4/13/2017
It's Official: Ovid CEO Just Filed for $86 Million IPO 4/13/2017
SEC Cracks Down on "Fake Biotech News" 4/12/2017
Shutdown Looming: Unilife  (UNIS) Files for Chapter 11 4/12/2017
Bay Area Avinger Cuts Workforce by 33% 4/12/2017
FDA Picks Boston's Emulate for its Organ-on-a-Chip Technology 4/12/2017
Boston's PureTech Gives Birth to New Biotech and Its Name is Nybo Therapeutics 4/12/2017
3 Drug Giants That Boasts the Best Pipelines 4/11/2017
Takeda (TKPYY) Splits Off a Range of Businesses to Focus on R&D 4/11/2017
These 3 Big Biotechs Could Have New Blockbuster Drugs Very Soon 4/10/2017
Finally! STADA Arzneimittel (STAGn.DE) Accepts $5.6 Billion Takeover Offer From Bain, Cinven 4/10/2017
FDA Finally Allows 23andMe to Sell At-Home DNA Tests for 10 Diseases 4/10/2017
Johnson & Johnson (JNJ) Forges Peptide Discovery Pact Worth $1.5 Billion With Japanese Biopharma Peptidream 4/7/2017



//-->